Connection

Meera Narasimhan to Schizophrenia

This is a "connection" page, showing publications Meera Narasimhan has written about Schizophrenia.
Connection Strength

1.109
  1. Simplifying adherence in schizophrenia. Psychiatr Serv. 2010 Apr; 61(4):405-8.
    View in: PubMed
    Score: 0.315
  2. Metabolic syndrome in patients with schizophrenia: CATIE results. Curr Psychiatry Rep. 2006 Jun; 8(3):213-4.
    View in: PubMed
    Score: 0.242
  3. Improving adherence to antipsychotic pharmacotherapy. Curr Clin Pharmacol. 2006 Jan; 1(1):47-56.
    View in: PubMed
    Score: 0.235
  4. Long-acting injectable vs oral risperidone for schizophrenia and co-occurring alcohol use disorder: a randomized trial. J Clin Psychiatry. 2015 Oct; 76(10):1359-65.
    View in: PubMed
    Score: 0.115
  5. Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale. Eur Neuropsychopharmacol. 2015 Feb; 25(2):176-84.
    View in: PubMed
    Score: 0.106
  6. Polypharmacy in pregnant women with major psychiatric illness: a pilot study. J Psychiatr Pract. 2007 Nov; 13(6):385-92.
    View in: PubMed
    Score: 0.067
  7. Validation of a Computerized test of Functional Capacity. Schizophr Res. 2016 08; 175(1-3):90-96.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.